According to the widely established cytoprotective role played by HO-1 in response to different pathological conditions, its upregulation could represent a valuable therapeutic strategy for the management of diseases as atherosclerosis, inflammation, vascular injury, hypoxia, and ischemia, as well as several metabolic dysfunctions [45,192]. This evidence concerns the gene HMOX1 and atherosclerosis.